6:24 PM
 | 
Jun 28, 2013
 |  BC Extra  |  Clinical News

Eleven reports first efficacy data for dry eye compound

Eleven Biotherapeutics Inc. (Cambridge, Mass.) said thrice-daily topical EBI-005 for six weeks significantly improved signs and symptoms of dry eye...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >